Literature DB >> 33820514

The Main Receptors Involved in the COVID-19: A Systematic Review and Meta-Analysis.

Alice Barros Câmara1, Igor Augusto Brandão1.   

Abstract

OBJECTIVE: This review aims to study the receptor's family and functions most related to COVID-19 infection and also suggest the tissue and cell location on which the majority of COVID-19 receptors are mainly expressed.
METHODS: This systematic review is according to PRISMA guidelines. PubMed, Cochrane, SciELO, Lilacs, Web of Science, and DOAJ databases were used. Clinical trials and research articles studying receptors related to COVID-19 were included in this review. R programming language was used to elaborate charts and receptors network, and SPSS(26v) software was used to perform statistical analysis (PROSPERO: CRD42020210643).
RESULTS: The majority of studies on the involvement of receptors in COVID-19 included plasma receptors and G protein-coupled receptor families (p<0.05). These receptors are highly expressed in the brain (24%) and 80% of them can interact with each other in a protein network, exerting some regulatory effects on various tissues. The main influential receptor in the network of receptors involved in the COVID-19 was the EGFR and the majority of receptors were associated with pathological processes of the disease (p<0.05), including the amplification of inflammatory responses in COVID-19, which may be related to neurological disorders in some cases. Studies on receptors involved in the COVID-19 included mainly patients from the United States, Spain, and Brazil (p<0.05).
CONCLUSION: Plasma receptors and G protein-coupled receptors, especially the EGFR, involved in pathological effects of the COVID-19 inflammatory process in the brain have shown significant importance in this review. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  Brain; COVID-19; G protein-coupled receptor; epidermal growth factor receptor; inflammation; plasmazzm321990receptors.

Mesh:

Substances:

Year:  2021        PMID: 33820514     DOI: 10.2174/0929867328666210405113253

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  2 in total

1.  Bioinformatics and in-silico findings reveal medical features and pharmacological targets of biochanin A against colorectal cancer and COVID-19.

Authors:  Jingru Qin; Chao Guo; Lu Yang; Xiao Liang; Aijun Jiao; Keng Po Lai; Bin Yang
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

2.  Nimotuzumab Increases the Recovery Rate of Severe and Critical COVID-19 Patients: Evaluation in the Real-World Scenario.

Authors:  Henrry Diaz; Jorge Jiménez; Aray Hernández; Leivis Valdés; Ariadna Martínez; Leonor Porto; Raity Hernández; Nadina Travieso; Julio Héctor Jova; Loipa Medel; Mayelin Troche; Annia Gorte; Delmis Batista; Ana Rosa Valls; Leticia Cabrera; Milagros Domeq; Leslie Pérez; Patricia Lorenzo-Luaces; Lizet Sánchez; Danay Saavedra; Mayra Ramos; Tania Crombet
Journal:  Front Public Health       Date:  2022-07-22
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.